Adaptation of Human iPSC-Derived Cardiomyocytes to Tyrosine Kinase Inhibitors Reduces Acute Cardiotoxicity via Metabolic Reprogramming
about
Adaptation of Human iPSC-Derived Cardiomyocytes to Tyrosine Kinase Inhibitors Reduces Acute Cardiotoxicity via Metabolic Reprogramming
description
scientific article published on 08 May 2019
@en
name
Adaptation of Human iPSC-Deriv ...... ty via Metabolic Reprogramming
@en
type
label
Adaptation of Human iPSC-Deriv ...... ty via Metabolic Reprogramming
@en
prefLabel
Adaptation of Human iPSC-Deriv ...... ty via Metabolic Reprogramming
@en
P2093
P1433
P1476
Adaptation of Human iPSC-Deriv ...... ty via Metabolic Reprogramming
@en
P2093
Alison E Ringel
Alison R Erickson
Connor A Jacobson
Kristina M Holton
Laura Maliszewski
Marcia C Haigis
Noga Ron-Harel
Robert A Everley
Robert P Sheehan
P304
412-426.e7
P356
10.1016/J.CELS.2019.03.009
P577
2019-05-08T00:00:00Z